Navigation Links
Zimbabwe Faces Shortage Of AIDS Drugs

A Summary Report by Los Angeles Times and Chicago Tribune

According to a report by the Chicago Tribune, HIV-positive Zimbabweans are having limited// access to antiretroviral drugs, owing to rising prices, dearth of foreign exchange to import drugs and President Robert Mugabe's drive on Urban Evictions. A report by the United Nations states that, hyperinflation in the last quarter has resulted in increased costs – for example a month’s supply of antiretrovirals in Zimbabwe that earlier costed $7.70 has escalated to $17. Simply unimaginable in Zimbabwe, where the average earning of a laborer is the equivalent of 20$a month.

The Los Angeles Times has named it, Zimbabwe's "economic collapse," where hyperinflation and unemployment are riding high. Along with this comes acute dearth of antiretrovirals and lifeline medications. Zimbabwean health officials are of the opinion that Zimbabwe’s lack of foreign exchange has caused a shortage of antiretrovirals, as the local manufacturers are not able to adequately import drug components. The past few years, in Zimbabwe, have been a witness to widespread political and economic disorder, resulting in decreased international donor finding. The Times report states that Doctors are extremely guarded about starting any antiretroviral initiatives until they are rest assured that such efforts will be backed up.

'"/>




Page: 1

Related medicine news :

1. Cholera outbreak in Zimbabwe
2. Spread Of AIDS Is Reduced Greatly In Zimbabwe Due To Change In Behavior
3. Zimbabweans Will Need To Cough Up More on Health Costs
4. UNICEF To Launch A Programme For Zimbabwe Children
5. Zimbabwe To Get £22-Million For Support Of AIDS/HIV Childre
6. Incentives to stop Zimbabwe skills exodus
7. Fight against HIV taken up by Zimbabwes Hairdressers
8. 200 Cattle Dead in Zimbabwe Due to Anthrax
9. Zimbabwe to Revive Human Organ Donation Programme
10. Women With High Oestrogen Levels Have Prettier Faces
11. Gynaecologist Faces Stiff Prison Sentence On Counts Of Sexual Abuse
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose Combination Drug ... p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose combination products ... increased attention from all stakeholders in the development of new chemical entities. , ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... Leadership Series at Zuckerberg San Francisco General Hospital on April 5-7. The series ... behaviors and create new habits. The workshops cover a broad range of topics, ...
(Date:2/12/2016)... , ... February 12, 2016 , ... The Jones Agency, ... communities across eastern Texas, is launching a cooperative charity drive with the Tarrant Area ... Serving more than 50,000 individuals and families in need, the Tarrant County Food Bank ...
(Date:2/12/2016)... ... ... Miami Dental Specialists is excited to bring patients the choice of ceramic, ... Dental Specialists will offer the non-metal implants as a safe, holistic and hygienic approach ... the dental implant manufacturer, Straumann, to bring this cutting-edge technology to Miami. ...
(Date:2/12/2016)... ... 2016 , ... Atlantic Information Services, Inc. (AIS) is pleased ... upcoming Feb. 24 webinar that will discuss ways health plans and PBMs are ... the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 inhibitors to treat cholesterol. ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Calif. , Feb. 12, 2016  SI-BONE, Inc., a medical ... ® ("iFuse"), a minimally invasive surgical (MIS) device indicated for ... National Government Services, Inc. (NGS), the Medicare Administrative Contractor (MAC) covering ... , Maine , Massachusetts ... , New York , Rhode Island ...
(Date:2/12/2016)... Calif. , Feb. 12, 2016  Sequent Medical, ... in a study to evaluate the safety and effectiveness ... the treatment of ruptured intracranial aneurysms.  Prof Laurent ... Hospital, in Paris, France and ... patient. France and Germany.  ...
(Date:2/12/2016)... Lilly and Company (NYSE: LLY ) today announced that ... regimen patent would not presently be infringed by Actavis marketing ... Italy and Spain ... solution.  --> --> ... that Lilly,s patent would be indirectly infringed by Actavis marketing ...
Breaking Medicine Technology: